Chou C C, Wu D
Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Chang Gung University College of Medicine, Taiwan, ROC.
Chang Gung Med J. 2001 Dec;24(12):805-9.
There is a growing list of drugs implicated in acquired long QT syndrome and torsade de pointes. However, the torsadogenic potential of metoclopramide, a commonly used antiemetic and prokinetic drug, has not been reported in the literature, despite its chemical similarity to procainamide. We report on a 92-year-old woman with preexisting complete left bundle branch block who developed torsade de pointes after intravenous and oral administration of metoclopramide. This patient also developed torsade de pointes when cisapride and erythromycin were given simultaneously. These two episodes were suppressed successfully after discontinuing the offending drugs and administering class IB drugs. This is the first documentation that metoclopramide provokes torsade de pointes clinically. Metoclopramide should be used cautiously in patients with a risk of torsade de pointes.
与获得性长QT综合征和尖端扭转型室速相关的药物越来越多。然而,尽管甲氧氯普胺(一种常用的止吐和促动力药物)与普鲁卡因胺在化学结构上相似,但其致尖端扭转型室速的可能性在文献中尚未见报道。我们报告了一名92岁的女性,她既往有完全性左束支传导阻滞,在静脉和口服甲氧氯普胺后发生了尖端扭转型室速。该患者在同时使用西沙必利和红霉素时也发生了尖端扭转型室速。停用相关药物并给予ⅠB类药物后,这两次发作均成功得到抑制。这是甲氧氯普胺在临床上诱发尖端扭转型室速的首次记录。对于有尖端扭转型室速风险的患者,应谨慎使用甲氧氯普胺。